Hamlet Protein

History

2012


HAMLET PROTEIN opens new plant in Findlay, Ohio, USA. It is the first time that the products of HAMLET PROTEIN are produced outside of Denmark.
2010


The product HP 350 Multi-bind is introduced, with its unique water- and fat-binding capacity it targets demanding feed applications
2009

As part of a planned generation change a new management team is appointed
2007


The Danish private equity fund Polaris acquires a majority shareholding (52%) with the aim to enhance growth in Europe and the USA
2006 Fifth expansion of the factory is completed
2006


Oelmühle Hamburg AG´s shares in HAMLET PROTEIN are acquired by companies controlled by Founder Ole Kaae Hansen and Sales Director Stephen Paul Rose
2004



New product is introduced to the piglet segment: The product HP 200 is made to increase growth and the health status when added to the starterfeed. The product is quickly a big success
2002 Fourth expansion of the factory is completed
2001


A new series of products are introduced. The products have increased digestibility of different minerals – especially phosphorous (e.g. for use in aquafeed)
2000


HAMLET PROTEIN completes a dedicated non-GMO production line and introduces non-GMO versions of the products for the first time
1998 Third expansion of the factory is completed
1996 Second expansion of the factory is completed
1994 First expansion of the factory is completed
1993




HAMLET PROTEIN commences commercial operations at the special purpose-built factory in Horsens, Denmark. Products of HP 100 series for the calves segment (for calf milk replacers) and HP 300 series for the piglet segment (for weaning feed) are introduced
1992

HAMLET PROTEIN is established as a Danish shareholding company with 50% Danish and 50% German shareholders
1989

Pilot plant trials are initiated by Ole Kaae Hansen and carried out at an old dairy plant in Horsens, Denmark

right1 benefits_GB

right2 ANF-soy_US